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Abstract
Rhythmic heartbeats are paced by electrical impulses that are autonomously
generated by cardiac pacemaker cells. This chapter briefly summarizes our
recent findings regarding the embryonic origin of and molecular mechanism
delineating cardiac pacemaker cells, showing that pacemaker cells are physi-
cally segregated and molecularly programmed, in a tertiary heart field, prior to
the onset of cardiac morphogenesis.
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39.1 Introduction
Rhythmic heartbeat is initiated by electrical impulses evoked at the sinoatrial node
(SAN) that are then conducted to atrial muscle and converge to the atrioventricular
node. After a brief delay, pacemaker-initiated action potentials (APs) rapidly pass
down the conduction system network and finally spread into ventricular muscle
(Fig. 39.1a). The SAN was first described more than a century ago [1], and its
anatomical, physiological, and molecular characteristics have been thoroughly
investigated [2]. While significant progress has been made in our understanding
of the mechanism responsible for the differentiation and patterning of the distal
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conduction components, the developmental pathway of the SAN remains contro-
versial (Fig. 39.1b).
The identification of the definitive origin of and inductive mechanisms that
define SAN pacemaker cells (PCs) will be critical for systematic investigation of
developmental mechanisms, such as cell fate specification and differentiation, of
this specialized cell population essential for cardiac function. We have recently
identified a novel role of Wnt signaling in promoting pacemaker cell induction and
differentiation, which is completely contrary to its well-documented inhibitory role
in heart field induction [3].
39.2 Pacemaking Site Transitions From Left To Right During
Heart Looping
Classic studies in the chick embryo have shown that as soon as the primitive heart
tube forms, myocytes in the posterior inflow tract become electrically active and
predominantly evoke pacemaking impulses [4]. While this population has been a
priori thought as the progenitor of the SAN pacemaker, no direct cell lineage-
tracing study has tested this dogma. Therefore, we have revisited this critical issue.
Consistent with previous studies, our optical mapping analysis has detected that the
primitive heart tube evokes APs preferentially at the left inflow. Importantly,
however, our fate mapping studies have revealed that cells of the left inflow later
differentiate into AV junction myocytes rather than the right side pacing cells at the
Fig. 39.1 (a) Diagram of the pacemaking and conduction system network consisting of distinct
subcomponents. (b) Controversies in the developmental pathway of SAN pacemaker cells. The
classic model assumes that this cell population differentiates from atrial myocytes. A current
dogma suggests that SAN pacemaker cells arise from a part of the heart field mesoderm which
remains as immature myocytes. These models are based on phenotypic similarities between
embryonic myocytes and SAN cells in action potential shape and the expression of unique
genes in common. The only way to reliably establish the origins of a cell type is to tag its
antecedents. Our direct cell fate mapping studies have identified an origin and novel developmen-
tal pathway for SAN pacemaker cells (proposed model)
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SA [5]. The above findings are consistent with a hypothesis that there are a
successive series of pacemaker zones present in the early developing heart [6],
indicating that the true origin of SAN pacemaker cells remains to be identified.
39.3 A Novel Cell Population That Juxtaposes the Right Atrium
Takes Over Pacing Function by Mid-heart Looping Stage
While classic and current models assume that SAN PCs arise from a subpopulation
of atrial precursors (Fig. 39.1b), to our surprise, our optical mapping data showed
that a small region juxtaposing the right atrium preferentially evokes pacemaking
action potentials [5]. This pacemaking site has often been neglected in previous
studies as this region is routinely dissected away during isolation of the embryonic
heart. Our optical mapping and in situ hybridization analyses [5] have identified
that this pacemaker site preferentially expresses HCN4, a major member of the
HCN gene family expressed in the heart responsible for the hyperpolarization-
activated inward “funny” current, and an atrial-type myosin AMHC1, but is nega-
tive for a cardiac transcription factor Nkx2-5 [9]. These are consistent with previous
reports on the adult mouse SAN. Other tissues of the conduction system, such as
AVN and Purkinje fibers, co-express HCNs and Nkx2-5. Thus, differentiated SAN
pacemaker cells can be distinguished by these physiological, pharmacological, and
molecular characteristics from other myocytes and conduction cells. Unfortunately,
expression of these marker genes is dynamic and no HCN4+/AMHC1+/Nkx2-5-
cells can be found in earlier stage embryos. It is therefore unclear when and where
SAN pacemaker cell fate is induced and specified. As the heart matures through the
processes of looping, heart primordium continually expands with cells being added
to both the inflow and outflow segments [7, 8]. The origin of this novel pacemaking
cell population needs to be determined.
39.4 The Right-Sided Pacemaking Cells Indeed Differentiate
into SAN Pacemaker Cells
Our in ovo cell-tracing studies have mapped the fate of these extracardiac right-
sided pacing cells to the physiologically correct SAN region of the resulting heart at
stage 35 (E9) [5]. Optical mapping of these labeled hearts has shown that action
potentials are predominantly evoked from these specific cells and propagate into the
atrium [5]. Thus, these studies have identified a novel extracardiac cell population
as SAN pacemaker precursors. However, until recently it was unknown where this
cell population came from. Indeed, the fate of cells in the inflow has been contro-
versial. No systematic fate mapping data was available about the pacemaker field
posterior to the heart field at pre-heart tube formation stages. Genetic lineage
tracing critically depends upon a gene that is exclusively expressed in pacemaker
precursors but not in daughter cells. To our knowledge, no such gene had been
identified to date. To explore the origin of SAN pacemaker cells, we performed fate
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mapping for earlier embryonic stages [5; Fig. 39.2]. For example, in stage 7–8
embryos, the PCs were mapped to a small region in the right lateral plate at somite
level 3. Importantly, “the pacemaker field (PF)” does not overlap with “the heart
field (HF)” defined by expression of either Nkx2-5 or Isl1 [9, 10]. The data show for
the first time that SAN precursors arise from an unpredicted small area of the lateral
mesoderm immediately posterior to the known HF. It should be noted that the PF is
embedded in the zone that also generates other cardiac-related tissues, such as the
proepicardium, right atrium, and vena cava (Bressan 2013). We therefore tenta-
tively termed this previously unrecognized mesodermal area “tertiary heart field,”
distinguishing it from the primary heart field and the secondary (anterior) heart field
(Fig. 39.3).
Fig. 39.2 Fate map of pacemaker field. (a) At early somite stages, heart precursors occupy
bilateral fields within the lateral plate mesoderm. The primary heart field is indicated in yellow, the
secondary heart field is indicated in pink, and the posterior tertiary heart field [5] is indicated in
blue. Fate mapping studies indicate the progenitors of the SAN pacemaker cells reside within the
tertiary heart field (asterisk). (b) At heart tube stages, the primary heart fields have fused along the
midline, while the secondary and tertiary heart fields have not yet been incorporated into the heart.
The pacemaker precursors maintain their position within the tertiary heart field mesoderm (blue).
(c) At looping stages, the pacemaker cells have incorporated into/can be seen attaching the right
inflow of the heart and begin to pace the heartbeat. at atria, avj atrioventricular junction, ht heart
tube, vt ventricle, a anterior, p posterior, r right, l left
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39.5 Pacemaker Cell Fate Specification Has Already Completed
Prior to Heart Morphogenesis
The fate mapping data alone however do not provide any information as to where
and when the pacemaker cell fate is specified. A protocol is needed to detect timing
and location of cell fate specification apart from marker gene expression. “The cell
fate specification” is defined by Harrison [11] and Slack [12] as “when a cell or a
tissue becomes capable of autonomously differentiating under a neutral environ-
ment, such as in petri dish or test tube.”
Using an established culture model that was previously used for studying classic
HF specification, we examined autonomous pacemaker differentiation from PF,
which has been mapped in stage 8 embryos (see Fig. 39.2). Under the neutral
culture condition, HF explants from stage 8 embryos initiated spontaneous
contractions within 24 h. Our data are consistent with previous studies on HF
specification. In striking contrast, PF explants did not show any contractions during
the first 24 h, but by 48 h many of them started rhythmic contractions with a higher
beat rate and exhibited AP waveform characteristic of PCs. PF explants continued
to rhythmically beat at a similar rate throughout the extended culture period for at
least up to 120 h. The data show that cells posterior to the HF autonomously
differentiate to initiate and maintain spontaneous rhythmic contractions, which
are distinct from those of the HF.
39.6 PF Explants Are Sensitive to Blockers Specific
for Pacemaking Ion Channel
Our pharmacological tests interrogated whether PF explants use ion channel char-
acteristic of pacemaker cells. Our data show that a HCN channel blocker, ZD7288,
induced PF explants to increase the interval between contractions by approximately
Fig. 39.3 Model for distinct
roles of Wnt signaling in HF
induction vs. PF induction
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~50 % without detectable loss of rhythmicity. An L-type Ca2+ channel blocker,
nifedipine, completely diminished spontaneous contraction of PF explants. These
pharmacological responses of PF explants are characteristic of SAN pacemaker
cells which evoke action potentials mainly through HCN channels and L-type Ca2+
channels and are distinct from cardiomyocytes which mainly use Na+ channels for
the upstroke of action potentials.
39.7 Current Models for Molecular Regulation of SAN
Pacemaker Differentiation
It was once postulated that the SAN pacemaker arises from a part of the HF
mesoderm which co-expresses Isl1 and Tbx18. Pitx2c, Shox2, Nkx2-5, Tbx3, and
Tbx5 are believed to play a role in SAN development. In mice, gene deletion of a
laterality gene, Pitx2c, leads to bilateral SANs. Shox2 deficiency results in
upregulation of Nkx2-5 and Cx43 in the SAN domain. Both Shox2 and Tbx3
expression require Tbx5. Because Nkx2-5 is absent in the SAN, Nkx2-5 is suggested
to suppress HCN4 and Tbx3. Tbx3 gene knockouts result in expression of atrial
genes in the SAN and partial loss of SAN-specific gene expression. Ectopic
expression of Tbx3 in the atria causes arrhythmia. Taken together, Tbx3 and
Tbx18 have been proposed as key transcription factors for SAN pacemaker differ-
entiation. Contradictory to these models, deletion of Tbx3, Tbx18, or Shox2 results
in no or only modest pacemaker defects. Further Tbx3 expression occurs at the AV
junction and AV node where Nkx2-5 is highly expressed. Our data have revealed,
however, that Tbx3, Tbx18, and Isl1 are absent from SAN pacemaker cells during
the early stages that correspond with cell fate specification and differentiation.
Thus, further elucidation was needed to better understand the molecular
mechanisms that regulate the specification and formation of SAN pacemaker cells.
39.8 A Novel Role of Wnt Signaling for Pacemaker Cell Fate
Specification
Heart field induction and specification are promoted by BMP signaling and are
restricted to the anterior region by inhibition of Wnt signaling [3, 13]. In chick, Wnt
from the neural plate ectoderm and the posterior mesoderm inhibits myocardial
differentiation in paraxial and posterior mesoderm, while the secreted Wnt antago-
nist, crescent, produced by the anterior endoderm supports myocardial develop-
ment. Noncanonical Wnts that block canonical Wnt/β-catenin signaling can act
positively on HF establishment and myocardial electro gradient. Isl1-Cre/β-catenin
mutants show defects in outflow tract formation with decreased expression of Tbx2,
Tbx3, Shh, and Wnt11. Canonical Wnt signaling is necessary for growth of second
HF-derived right ventricular myocytes during heart looping and onward but its role
for early specification of the second HF remains obscure. Taken together, inhibition
of canonical Wnt/β-catenin signaling is critical for restricting heart field induction
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to the anterior mesoderm. In contrast to extensive studies of heart field formation,
little is known about Wnt signaling in pacemaker development.
Activation of Wnt signaling in the HF diminishes the expression of several
cardiac genes, including Nkx2-5. However, it remains largely unknown what HF
fate becomes once “HF identity” is lost. Our fate mapping data indicated a
surprisingly posterior origin for pacemaker cell progenitors within the Nkx2.5
negative mesoderm, as well as an earlier timing of specification than previously
believed. These results led us to reexamine the question of heart field identity
following loss of Nkx2.5. Therefore, we investigated this untouched area of Wnt
signaling on heart field cells using physiological approaches. Our data have
revealed that Wnt-treated heart field cells do not lose contractility either in vivo
or in vitro. Instead, they developed a rhythmic, high-rate contraction pattern similar
to PF explants, including AP waveforms reminiscent of PCs [5]. A transient
exposure to Wnt for only 8 h was sufficient to obtain the pacemaker-like beating
pattern. Our in vivo and in vitro data have further demonstrated that inhibition of
Wnt signaling for pacemaker progenitors results in a conversion of their fate to the
ordinary cardiomyocyte type.
39.9 Concluding Remarks
An elucidation of the origin and molecular mechanisms that specify the pacemaker
cell fate is fundamental to dissecting the earliest steps critical for SAN pacemaker
development. Our data have revealed that the pacemaker cell fate is specified in a
previously unconsidered embryonic region at very early embryonic stages even
before heart morphogenesis begins. The work has also revealed that differential
Wnt-mediated signaling cues in the lateral plate mesoderm are sufficient to induce
pacemaker-like versus working myocardial fates, and that these fates are
maintained throughout early cardiac morphogenesis. These results will significantly
increase our understanding of the basis for the mechanisms that regulate pacemaker
cell specification and differentiation.
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